HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes - Wikidata - wikimedia - TriplyDB

HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes

HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes

http://www.wikidata.org/entity/Q35978622

about

Human CD8 T lymphocytes recognize Mycobacterium tuberculosis antigens presented by HLA-E during active tuberculosis and express type 2 cytokines Structural basis for NKG2A/CD94 recognition of HLA-E.Various hypotheses on MHC evolution suggested by the concerted evolution of CD94L and MHC class Ia molecules Immune regulation of human herpesviruses and its implications for human transplantation Innovative Strategies to Identify M. tuberculosis Antigens and Epitopes Using Genome-Wide Analyses CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence The Structure and Stability of the Monomorphic HLA-G Are Influenced by the Nature of the Bound Peptide Functional Reconstitution of Natural Killer Cells in Allogeneic Hematopoietic Stem Cell Transplantation Characteristics of HLA-E Restricted T-Cell Responses and Their Role in Infectious Diseases IL-12-producing monocytes and HLA-E control HCMV-driven NKG2C+ NK cell expansion An MHC class Ib-restricted CD8 T cell response confers antiviral immunity Structural basis for a major histocompatibility complex class Ib-restricted T cell response Mycobacterium tuberculosis peptides presented by HLA-E molecules are targets for human CD8 T-cells with cytotoxic as well as regulatory activity Modulation of natural killer cells by human cytomegalovirus.Ex Vivo kinetics of early and long-term multifunctional human leukocyte antigen E-specific CD8+ cells in volunteers immunized with the Ty21a typhoid vaccine.HLA-E-restricted cross-recognition of allogeneic endothelial cells by CMV-associated CD8 T cells: a potential risk factor following transplantation.Diverse roles of non-diverse molecules: MHC class Ib molecules in host defense and control of autoimmunity Nonconventional CD8+ T cell responses to Listeria infection in mice lacking MHC class Ia and H2-M3.Positive selecting cell type determines the phenotype of MHC class Ib-restricted CD8+ T cells.Human CD8+ T-cells recognizing peptides from Mycobacterium tuberculosis (Mtb) presented by HLA-E have an unorthodox Th2-like, multifunctional, Mtb inhibitory phenotype and represent a novel human T-cell subset.The Presence of HLA-E-Restricted, CMV-Specific CD8+ T Cells in the Blood of Lung Transplant Recipients Correlates with Chronic Allograft Rejection Human cytomegalovirus UL40 signal peptide regulates cell surface expression of the NK cell ligands HLA-E and gpUL18 Human Leukocyte Antigen-E Alleles are Associated with Hepatitis C Virus, Torque Teno Virus, and Toxoplasma Co-infections but are not Associated with Hepatitis B Virus, Hepatitis D Virus, and GB Virus C Co-infections in Human Immunodeficiency Virus P Regulation of self-tolerance by Qa-1-restricted CD8(+) regulatory T cells The diversity of the HLA-E-restricted peptide repertoire explains the immunological impact of the Arg107Gly mismatch.Peptide immunization elicits polyomavirus-specific MHC class ib-restricted CD8 T cells in MHC class ia allogeneic mice.Play it in E or G: utilization of HLA-E and -G in xenotransplantation.CD8+ effector T cells at the fetal-maternal interface, balancing fetal tolerance and antiviral immunity.Immunity to Polyomavirus BK Infection: Immune Monitoring to Regulate the Balance between Risk of BKV Nephropathy and Induction of Alloimmunity.Antiviral NK cell responses in HIV infection: II. viral strategies for evasion and lessons for immunotherapy and vaccination.HLA-E(⁎)01:03 Allele in Lung Transplant Recipients Correlates with Higher Chronic Lung Allograft Dysfunction Occurrence.Non-classical MHC-E (Mamu-E) expression in the rhesus monkey placenta.The emerging role of HLA-E-restricted CD8+ T lymphocytes in the adaptive immune response to pathogens and tumors.Clinical significance of the HLA-E and CD94/NKG2 interaction.Human leukocyte antigen E in human cytomegalovirus infection: friend or foe?At the Bench: Preclinical rationale for exploiting NK cells and γδ T lymphocytes for the treatment of high-risk leukemias.HLA-E: a novel player for histocompatibility.Clinical and immunological significance of HLA-E in stem cell transplantation and cancer.Classical and non-classical MHC I molecule manipulation by human cytomegalovirus: so many targets—but how many arrows in the quiver?NLRP2 is a suppressor of NF-ƙB signaling and HLA-C expression in human trophoblasts†,‡.

P2860

Q24316479-567B30E5-6FAE-43D4-8726-2C4DD3205846 Q24336854-93D7A4BA-698C-48CE-A60A-543065BB5E32 Q25256392-9A3D2660-6822-4B10-8889-01DACEC8E6A7 Q26992146-94D29740-8645-46FF-A271-ADEF10DCDB1B Q27027110-73F3CEC1-52B6-4C08-8426-403AA8E7104C Q27650047-BF3837B3-038D-415C-A19F-7B63A5A993E5 Q27659367-664C18A4-C79C-41A4-8B55-4D1B4FD5B43B Q28069682-B05A4F99-A9F9-4AED-83AE-81D876B3E77F Q28079186-70B9E87B-A318-4CA6-A199-A2AD1C2E340B Q28251295-CC6354CF-5C40-41BF-B17D-20801AF067AD Q28510308-D28D3F86-560B-4C26-9BB7-736F8EE04CF6 Q28941762-5CFC898E-6087-45C3-BEC2-F8890BEBA321 Q33535876-9752DA28-F435-4973-B62B-AD131CC1D611 Q33744384-E4194BD5-9A00-4057-B3BB-DD1ED3141056 Q34150391-4B163597-3A2E-4B22-97D2-9000B89F595D Q34506165-AF9E1D5C-B766-443E-B9E4-E250EA4D5DA9 Q34626935-E151A03F-1775-4564-91CF-930D050642AC Q34748695-4351E733-E1D4-433B-AAC7-E2241C0FDCC9 Q35164668-07668052-4BEE-4E99-990C-3378C4523271 Q35214233-C89AA784-74FE-43E3-A9E2-7D1AE2CF0F13 Q35753770-92461D46-8614-4173-8796-4542C717C178 Q35828380-39B21E02-61FA-4123-BC3A-2E28D3032EAD Q36049911-BBD7DF70-E5EB-4770-89B9-3D6462D81B82 Q36244210-04BA0A2C-1F83-4920-87F6-161C9C318808 Q36431461-7376C0AA-5905-43F0-B03C-F0F776A9BBBB Q36626711-ADC676F3-6C32-40A6-BBE1-571B5A7D41F7 Q36816090-99B45979-F9B1-4EC2-B03F-1F13CBA9BD16 Q37014401-6469FE20-261D-4A7B-BFBC-520B5E5C86E0 Q37127201-BE6DB538-0161-46A4-9922-AE83C160500B Q37128257-65BED118-94DD-4481-8E34-F246CA0FEC02 Q37140147-B4C4D5A0-EF91-4C15-8C1A-4635A1F27B42 Q37369690-ABA6463F-B4F3-4F9A-A8AD-54A6E040B091 Q37773161-7A266227-2F7D-48A4-9B39-32E4926F43A8 Q37907929-EE8A042B-7E48-4785-A981-D8695F726E39 Q38009207-17E4EF12-18D5-4EB0-9F40-A9F78D1D6AA2 Q38151057-DD0CB63B-28EC-425D-8C4A-B935F46E01D9 Q38268679-B2A95DCE-E9A2-4E1B-8553-DD19B66FAED1 Q38270003-C00F02A7-7853-40CD-8D7D-8020F7F758E2 Q38270735-59B52B38-78CE-49DD-918B-C9193ACF5672 Q38710699-2DF92D54-DC43-4AC0-8E4C-A679A884CCBD

P2860

HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes

http://www.wikidata.org/entity/Q35978622

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

HLA-E-restricted recognition o ...... n CD8+ cytolytic T lymphocytes

@ast

HLA-E-restricted recognition o ...... n CD8+ cytolytic T lymphocytes

@en

type

label

HLA-E-restricted recognition o ...... n CD8+ cytolytic T lymphocytes

@ast

HLA-E-restricted recognition o ...... n CD8+ cytolytic T lymphocytes

@en

prefLabel

HLA-E-restricted recognition o ...... n CD8+ cytolytic T lymphocytes

@ast

HLA-E-restricted recognition o ...... n CD8+ cytolytic T lymphocytes

@en

P1433

Q35978622-1EECADC1-83BB-45C9-8B96-7EE98758D95D

P1476

Q35978622-09A92EAA-2AEE-496C-93B2-71BABF80F557

P2093

Q35978622-09FBA64B-F6BB-496F-AE7D-80F8BDC5211E

Q35978622-1DFBB3DC-DE21-4CA2-990D-6F322BAB6959

Q35978622-2B78D0A7-108D-4506-9C5E-12EBA8512334

Q35978622-2BE335C0-8866-4F53-96F2-58A7741E44B7

Q35978622-69237107-376D-48D1-AF49-C7CBF849F6CF

Q35978622-82530CC2-F3F1-45BD-9120-DE092A78EA4E

P2860

Q35978622-04936DCE-E221-48CC-9A1B-8FC6BCE6085F

Q35978622-08562D52-7477-44C5-97DC-381DBA9262BF

Q35978622-0E7A9E4F-A1F6-40C6-8408-9EFC9165F1A4

Q35978622-1C570980-E537-4DA4-856F-50B2E16CC2B2

Q35978622-1E2A8C57-DC37-4194-BAAE-792957A472AB

Q35978622-1FD7EDB8-0BED-4C4D-89F2-B6589A407E26

Q35978622-2F1FE67D-738A-45D4-B675-B63CBCF0027D

Q35978622-33626488-5416-4477-AB8B-98BA883A6C36

Q35978622-3455E9F9-B63C-4401-B6B3-042ACB2C6ACF

Q35978622-37CBA929-D60E-46EC-AECC-80A19C0AC6A2

P304

Q35978622-B8D96D85-1E95-4299-AE2F-8C79256AD520

P31

Q35978622-6B6F7303-85B7-41E5-9DFF-078D614D2026

P356

Q35978622-D381E732-ED2A-4CBB-ADF0-13D5437B9C1D

P407

Q35978622-905B461F-7F8F-43C7-8564-87CC524C07A9

P433

Q35978622-14CB06E7-B580-4DB4-9B18-1BFC5F2159FE

P478

Q35978622-B37754A9-BCBE-4BA3-923A-52B29B6C0DED

P50

Q35978622-175B54E4-8EBB-4E0F-A997-63430FA0C432

Q35978622-9BDF5D60-957F-4D2D-8558-0E0F051CF3E8

P577

Q35978622-D2EE1DD6-94E1-4E4E-894F-0E6259691975

P5875

Q35978622-93D1285E-2468-467E-A6F6-BC6EEE176527

P698

Q35978622-D0DEE24E-CC2E-4ED5-A6C8-C6B2768DB8DD

P921

Q35978622-86B4828B-5497-402F-920E-85919F1B6D19

P932

Q35978622-96C6491F-C013-4438-99D0-C242007A901F

P356

PNAS.1834449100

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

HLA-E-restricted recognition o ...... n CD8+ cytolytic T lymphocytes

@en

P2093

Alessandro Moretta

http://www.w3.org/2001/XMLSchema#string

Gabriella Pietra

http://www.w3.org/2001/XMLSchema#string

Lorenzo Moretta

http://www.w3.org/2001/XMLSchema#string

Maria Cristina Mingari

http://www.w3.org/2001/XMLSchema#string

Michela Falco

http://www.w3.org/2001/XMLSchema#string

Paola Mazzarino

http://www.w3.org/2001/XMLSchema#string

P2860

The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9

HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C

Structure and function of the human MHC class Ib molecules HLA-E, HLA-F and HLA-G

MHC class Ib-restricted CTL provide protection against primary and secondary Listeria monocytogenes infection

Molecular mimicry mediated by MHC class Ib molecules after infection with gram-negative pathogens.

Regulation of KIR expression in human T cells: a safety mechanism that may impair protective T-cell responses.

Functions of nonclassical MHC and non-MHC-encoded class I molecules.

Degradation of cell proteins and the generation of MHC class I-presented peptides.

Betaherpesviruses in transplant recipients.

The immunogenicity of human and murine cytomegaloviruses.

P304

10896-10901

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1834449100

http://www.w3.org/2001/XMLSchema#string

P407

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P50

Chiara Romagnani

P577

2003-09-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10579297

http://www.w3.org/2001/XMLSchema#string

P698

12960383

http://www.w3.org/2001/XMLSchema#string

P921

Cytomegalovirus

P932

196899

http://www.w3.org/2001/XMLSchema#string